Secretome analysis of human oligodendrocytes derived from neural stem cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Kim, Woo Kyung ^a,b,c   Kim, Deokhoon ^b   Cui, Jun ^a   Jang, Ho Hee ^a   Kim, Kwang Sei ^d   Lee, Hong Jun ^d   Kim, Seung U ^d,e   Ahn, Sung Min ^b  

^a Gachon University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c CJ Cheiljedang   (South Korea)

^d Chung Ang University College of Medicine   (South Korea)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CYTOKINES; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; OLIGODENDROGLIA; ORGAN SPECIFICITY; PROTEOME; PROTEOMICS; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TRANSDUCTION, GENETIC;

EID: 84894277909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0084292     Document Type: Article

References (97)

1. Peters A (1964) Observations on the connexions between myelin sheaths and glial cells in the optic nerves of young rats. J Anat 98: 125-134.4.
2. Bunge MB, Bunge RP, Pappas GD (1962) Electron microscopic demonstration of connections between glia and myelin sheaths in the developing mammalian central nervous system. J Cell Biol 12: 448-453.
3. Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Crowe MS (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat Med 3: 73-76. (Pubitemid 27019144)
4. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120: 393-399. (Pubitemid 27153632)
5. Lovas G, Szilágyi N, Majtényi K, Palkovits M, Komoly S (2000) Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 123: 308-317. (Pubitemid 30055154)
6. McFarlin DE, McFarland HF (1982) Multiple sclerosis. N Engl J Med 307: 1246-1251.
7. Paty D, Ebers G (1988) Multiple Sclerosis. Philadelphia: F. A. Davis.
8. Copray S, Balasubramaniyan V, Levenga J, de Bruijn J, Liem R, et al. (2006) Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes. Stem Cells 24: 1001-1010. (Pubitemid 44464733)
9. Espinosa de los Monteros A, Zhao P, Huang C, Pan T, Chang R, et al. (1997) Transplantation of CG4 oligodendrocyte progenitor cells in the myelin-deficient rat brain results in myelination of axons and enhanced oligodendroglial markers. J Neurosci Res 50: 872-887. (Pubitemid 27518283)
10. Kim SU (2004) Human neural stem cells genetically modified for brain repair in neurological disorders. Neuropathology 24, 159-174, 2004.
11. Kim SU, Nagai A, Nakagawa E, Choi HB, Bang JH, et al. (2008) Production and characterization of immortal human neural stem cell line with multipotent differentiation property. Methods Mol Biol 438: 103-121.
12. Kim SU, de Vellis J (2009) Stem cell-based cell therapy in neurological disease: A review. J Neurosci Res 88: 2183-2200.
13. Carpentier PA, Palmer TD (2009) Immune influence on adult neural stem cell regulation and function. Neuron 64: 79-92.
14. Deverman BE, Patterson PH (2009) Cytokines and CNS development. Neuron 64: 61-78.
15. Ahn S-M, Byun K, Kim D, Lee K, Yoo JS, et al. (2008) Olig2-induced neural stem cell differentiation involves downregulation of Wnt signaling and induction of Dickkopf-1 expression. PLoS ONE 3: e3917.
16. Hwang D, Kim B, Kim E, Lee S, Joo I, et al. (2009) Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury. BMC Neurosci 10: 117.
17. Wang L, Feng Z, Wang X, Wang X, Zhang X (2010) DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinforma Oxf Engl 26: 136-138.
18. Chen Y, Zhang Y, Yin Y, Gao G, Li S, et al. (2005) SPD-a web-based secreted protein database. Nucleic Acids Res 33: D169-D173. (Pubitemid 40207853)
19. Aboody KS, Bush RA, Garcia E, Metz MZ, Najbauer J, et al. (2006) Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE 1: e23.
20. Chu K, Kim M, Jeong S-W, Kim SU, Yoon B-W (2003) Human neural stem cells can migrate, differentiate, and integrate after intravenous transplantation in adult rats with transient forebrain ischemia. Neurosci Lett 343: 129-133. (Pubitemid 36577532)
21. Lee HJ, Kim KS, Kim EJ, Choi HB, Lee KH, et al. (2007) Brain transplantation of immortalized human neural stem cells promotes functional recovery in mouse intracerebral hemorrhage stroke model. Stem Cells 25: 1204-1212. (Pubitemid 46684880)
22. Ryu JK, Kim J, Cho SJ, Hatori K, Nagai A, et al. (2004) Proactive transplantation of human neural stem cells prevents degeneration of striatal neurons in a rat model of Huntington disease. Neurobiol Dis 16: 68-77. (Pubitemid 38569797)
23. Yasuhara T, Matsukawa N, Hara K, Yu G, Xu L, et al. (2006) Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease. J Neurosci 26: 12497-12511. (Pubitemid 44864515)
24. Kim SU, Moretto G, Shin DH (1985) Expression of Ia antigens on the surface of human oligodendrocytes and astrocytes in culture. J Neuroimmunol 10: 141- 149.
25. Kim SU (1990) Neurobiology of human oligodendrocytes in culture. J Neurosci Res 27: 712-728.
26. Graham V, Khudyakov J, Ellis P, Pevny L (2003) SOX2 functions to maintain neural progenitor identity. Neuron 39: 749-765. (Pubitemid 37088088)
27. Pevny LH, Nicolis SK (2010) Sox2 roles in neural stem cells. Internat J Biochem Cell Biol 42: 421-424.
28. Sprinkle TJ (1989) 29, 39-cyclic nucleotide 39-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4: 235-301.
29. Ahmed S, Gan H, Lam CS, Poonepalli A, Ramasamy S, et al. (2009) Transcription factors and neural stem cell self-renewal, growth and differentiation. Cell Adhes Migrat 3: 412-424.
30. Liu Z, Hu X, Cai J, Liu B, Peng X, et al. (2007) Induction of oligodendrocyte differentiation by Olig2 and Sox10: evidence for reciprocal interactions and dosage-dependent mechanisms. Dev Biol 302: 683-693. (Pubitemid 46216266)
31. Baumann N, Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev 81: 871-927. (Pubitemid 32267079)
32. Briscoe J, Chen Y, Jessell TM, Struhl G (2001) A Hedgehog-insensitive form of patched provides evidence for direct long-range morphogen activity of sonic hedgehog in the neural tube. Mol Cell 7: 1279-1291. (Pubitemid 32607361)
33. Gritli-Linde A, Lewis P, McMahon AP, Linde A (2001) The whereabouts of a morphogen: direct evidence for short- and graded long-range activity of hedgehog signaling peptides. Dev Biol 236: 364-386. (Pubitemid 32756991)
34. Ingham PW, McMahon AP (2001) Hedgehog signaling in animal development: paradigms and principles. Genes Dev 15: 3059-3087. (Pubitemid 33115673)
35. Inestrosa NC, Arenas E (2010) Emerging roles of Wnts in the adult nervous system. Nat Rev Neurosci 11: 77-86.
36. Kuwabara T, Hsieh J, Muotri A, Yeo G, Warashina M, et al. (2009) Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Nat Neurosci 12: 1097-1105.
37. Artavanis-Tsakonas S, Rand MD, Lake RJ (1999) Notch signaling: cell fate control and signal integration in development. Science 284: 770-776. (Pubitemid 29291335)
38. Miele L, Osborne B (1999) Arbiter of differentiation and death: Notch signaling meets apoptosis. J Cell Physiol 181: 393-409. (Pubitemid 29513408)
39. Louvi A, Artavanis-Tsakonas S (2006) Notch signalling in vertebrate neural development. Nat Rev Neurosci 7: 93-102. (Pubitemid 43151596)
40. Wen S, Li H, Liu J (2009) Dynamic signaling for neural stem cell fate determination. Cell Adhes Migr 3: 107-117.
41. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, et al. (2005) The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 33: D284-D288. (Pubitemid 40207879)
42. Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, et al. (2003) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13: 2129-2141. (Pubitemid 37161770)
43. Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, et al. (2004) Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Mol Cell Neurosci 25: 301-311. (Pubitemid 38338641)
44. Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, et al. (2002) Soluble Interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol Cell Neurosci 21: 602-615. (Pubitemid 36062717)
45. Zhang P, Chebath J, Lonai P, Revel M (2004) Enhancement of oligodendrocyte differentiation from murine embryonic stem cells by an activator of gp130 signaling. Stem Cells 22: 344-354. (Pubitemid 38736618)
46. Mey J, Henkes L (2002) Retinoic acid enhances leukemia inhibitory factor expression in OLN-93 oligodendrocytes. Cell Tissue Res 310: 155-161. (Pubitemid 36015566)
47. Kitada M, Rowitch DH (2006) Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. Glia 54: 35-46. (Pubitemid 43980032)
48. Omari KM, John GR, Sealfon SC, Raine CS (2005) CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 128: 1003-1015. (Pubitemid 40675456)
49. Kadi L, Selvaraju R, de Lys P, Proudfoot AEI, Wells TNC, et al. (2006) Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro. J Neuroimmunol 174: 133-146. (Pubitemid 44389492)
50. Schmitz T, Chew L-J (2008) Cytokines and myelination in the central nervous system. Sci World J 8: 1119-1147.
51. Tsai H-H, Frost E, To V, Robinson S, ffrench-Constant C, et al. (2002) The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration. Cell 110: 373-383.
52. Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P (1988) Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor ceil. Nature 333: 560-562.
53. Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcg M (1988) A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell 53: 309-319.
54. Chun SJ, Rasband MN, Sidman RL, Habib AA, Vartanian T (2003) Integrin-linked kinase is required for laminin-2-induced oligodendrocyte cell spreading and CNS myelination. J Cell Biol 163: 397-408. (Pubitemid 37363139)
55. Fernandez-Valle C, Fregien N, Wood PM, Bunge MB (1993) Expression of the protein zero myelin gene in axon-related Schwann cells is linked to basal lamina formation. Development 119: 867-880. (Pubitemid 23337427)
56. Masaki T (2012) Polarization and myelination in myelinating glia. ISRN Neurol 2012: 1-28.
57. Relucio J, Menezes MJ, Miyagoe-Suzuki Y, Takeda S, Colognato H (2012) Laminin regulates postnatal oligodendrocyte production by promoting oligodendrocyte progenitor survival in the subventricular zone. Glia 60: 1451-1467.
58. Tsiper MV, Yurchenco PD (2002) Laminin assembles into separate basement membrane and fibrillar matrices in Schwann cells. J Cell Sci 115: 1005-1015. (Pubitemid 34257385)
59. Matsumura K, Yamada H, Saito F, Sunada Y, Shimizu T (1997) Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromusl Dis 7: 7-12. (Pubitemid 27122405)
60. Goldman S (2005) Stem and progenitor cell-based therapy of the human central nervous system. Nat Biotech 23: 862-871.
61. Mewar R, McMorris FA (1997) Expression of insulin-like growth factor-binding protein messenger RNAs in developing rat oligodendrocytes and astrocytes. J Neurosci Res 50: 721-728. (Pubitemid 27518269)
62. Pasquini LA, Millet V, Hoyos HC, Giannoni JP, Croci DO, et al. (2011) Galectin-3 drives oligodendrocyte differentiation to control myelin integrity and function. Cell Death Differ 18: 1746-1756.
63. Filipovic R, Jakovcevski I, Zecevic N (2003) GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions. Dev Neurosci 25: 279-290. (Pubitemid 37100220)
64. Solé S, Petegnief V, Gorina R, Chamorro A, Planas AM (2004) Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion. J Neuropathol Exp Neurol 63: 338-349. (Pubitemid 38429031)
65. Oh LYS, Larsen PH, Krekoski CA, Edwards DR, Donovan F, et al. (1999) Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19: 8464-8475. (Pubitemid 30226765)
66. Uhm JH, Dooley NP, Oh LYS, Yong VW (1998) Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22: 53-63. (Pubitemid 28038043)
67. Larsen PH, Yong VW (2004) The expression of matrix metalloproteinase-12 by oligodendrocytes regulates their maturation and morphological differentiation. J Neurosci 24: 7597-7603. (Pubitemid 39186813)
68. Larsen PH, DaSilva AG, Conant K, Yong VW (2006) Myelin formation during development of the CNS is delayed in matrix metalloproteinase-9 and -12 null mice. J Neurosci 26: 2207-2214. (Pubitemid 44699029)
69. Kim Y, Remacle AG, Chernov AV, Liu H, Shubayev I, et al. (2012) The MMP-9/TIMP-1 axis controls the status of differentiation and function of myelin-forming schwann cells in nerve regeneration. PLoS ONE 7: e33664.
70. Yan L, Borregaard N, Kjeldsen L, Moses MA (2001) The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276: 37258-37265.
71. Ochieng J, Fridman R, Nangia-Makker P, Kleiner DE, Liotta LA, et al. (1994) Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33: 14109-14114. (Pubitemid 24382354)
72. Ould-yahoui A, Tremblay E, Sbai O, Ferhat L, Bernard A, et al. (2009) A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons. PLoS ONE 4: e8289.
73. Gross RE, Mehler MF, Mabie PC, Zang Z, Santschi L, et al. (1996) Bone morphogenetic proteins promote astroglial lineage commitment by mammalian subventricular zone progenitor cells. Neuron 17: 595-606. (Pubitemid 26365340)
74. Mabie PC, Mehler MF, Kessler JA (1999) Multiple roles of bone morphogenetic protein signaling in the regulation of cortical cell number and phenotype. J Neurosci 19: 7077-7088. (Pubitemid 29380133)
75. Mehler MF, Mabie PC, Zhu G, Gokhan S, Kessler JA (2000) Developmental changes in progenitor cell responsiveness to bone morphogenetic proteins differentially modulate progressive CNS lineage fate. Dev Neurosci 22: 74-85. (Pubitemid 30098908)
76. Mekki-Dauriac S, Agius E, Kan P, Cochard P (2002) Bone morphogenetic proteins negatively control oligodendrocyte precursor specification in the chick spinal cord. Development 129: 5117-5130. (Pubitemid 35460676)
77. Lee SC, Liu W, Brosnan CF, Dickson DW (1994) GM-CSF promotes proliferation of human fetal and adult microglia in primary cultures. Glia 12: 309-318.
78. Guillemin G, Boussin FD, Le Grand R, Croitoru J, Coffigny H, et al. (1996) Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains. Glia 16: 71-80. (Pubitemid 26350513)
79. Schäbitz W-R, Krüger C, Pitzer C, Weber D, Laage R, et al. (2008) A neuroprotective function for the hematopoietic protein granulocyte-macrophage colony stimulating factor (GM-CSF). J Cereb Blood Flow Metab 28: 29-43.
80. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, et al. (1997) Biology and action of colony-stimulating factor-1. Mol Reprod Dev 46: 4-10. (Pubitemid 27021347)
81. Nandi S, Gokhan S, Dai X-M, Wei S, Enikolopov G, et al. (2012) The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Dev Biol 367: 100-113.
82. Smidt MP, Schaick HSA van, Lanctôt C, Tremblay JJ, Cox JJ, et al. (1997) A homeodomain gene Ptx3 has highly restricted brain expression in mesencephalic dopaminergic neurons. Proc Natl Acad Sci USA 94: 13305-13310. (Pubitemid 27518517)
83. Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH (1998) The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci 18: 10457-10463. (Pubitemid 29016565)
84. Hosking MP, Tirotta E, Ransohoff RM, Lane TE (2010) CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination. PLoS ONE 5: e11340.
85. Choi JK, Choi BH, Ha Y, Park H, Yoon SH, et al. (2007) Signal transduction pathways of GM-CSF in neural cell lines. Neurosci Let 420: 217-222. (Pubitemid 46856005)
86. Choi JK, Kim KH, Park H, Park SR, Choi BH (2011) Granulocyte macrophage-colony stimulating factor shows anti-apoptotic activity in neural progenitor cells via JAK/STAT5-Bcl-2 pathway. Apoptosis 16: 127-134.
87. Kahn MA, De Vellis J (1994) Regulation of an oligodendrocyte progenitor cell line by the interleukin-6 family of cytokines. Glia 12: 87-98. (Pubitemid 2153354)
88. Balabanov R, Strand K, Goswami R, McMahon E, Begolka W, et al. (2007) Interferon-γ-Oligodendrocyte interactions in the regulation of experimental autoimmune encephalomyelitis. J Neurosci 27: 2013-2024.
89. Omari KM, Lutz SE, Santambrogio L, Lira SA, Raine CS (2009) Neuroprotection and Remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1. Amer J Path 174: 164-176.
90. Warner RL, Bhagavathula N, Nerusu KC, Lateef H, Younkin E, et al. (2004) Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro. Exp Mol Pathol 76: 189-195. (Pubitemid 38569779)
91. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA (1990) FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron 5: 603-614.
92. Chandran S, Kato H, Gerreli D, Compston A, Svendsen CN, et al. (2003) FGF-dependent generation of oligodendrocytes by a hedgehog-independent pathway. Development 130: 6599-6609. (Pubitemid 38088859)
93. Furusho M, Kaga Y, Ishii A, Hébert JM, Bansal R (2011) Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain. J Neurosci 31: 5055-5066.
94. Messersmith DJ, Murtie JC, Le TQ, Frost EE, Armstrong RC (2000) Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J Neurosci Res 62: 241-256.
95. Murtie JC, Zhou Y-X, Le TQ, Armstrong RC (2005) In vivo analysis of oligodendrocyte lineage development in postnatal FGF2 null mice. Glia 49: 542- 554.
96. Bansal R (2002) Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev Neurosci 24: 35-46.
97. Erlandsson A, Larsson J, Forsberg-Nilsson K (2004) Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp Cell Res 301: 201-210. (Pubitemid 39504973)